XFOR
X4 Pharmaceuticals Inc
2.80$
-2.4%
vs. previous close
Closing price · As of: Oct 1, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | -726.3% | -1,601.8% | -1,960.6% | – | – | – | -5,119.3% | -243.8% | |
| – | – | – | 2.9% | 3.4% | 41.0% | – | – | – | 31.1% | 3.6% | |
| – | – | – | 160.6% | 68.3% | 180.9% | – | – | – | 320.8% | 12.2% | |
| – | – | – | 127.9% | 239.7% | 216.4% | – | – | – | – | – | |
| – | – | – | 89.6% | -107.9% | -135.4% | – | – | – | 104.6% | -7.3% | |
| – | – | – | 1.0% | 5.8% | 45.4% | – | – | – | 286.5% | 8.5% | |
| – | – | – | -1.0% | 907.7% | -45.4% | – | – | – | 2,619.9% | 23.2% | |
| – | – | – | – | 665.1% | 412.9% | – | – | – | – | – | |
| – | – | – | -32.2% | 665.1% | -9.2% | – | – | – | – | – | |
| – | – | – | 100.8% | 16.0% | 412.9% | – | – | – | 782.2% | 0.0% | |
| – | – | – | 196.3% | 4,688.7% | 413.1% | – | – | – | 793.7% | 679.6% | |
| – | – | – | -1,961.7% | 3,986.3% | -1,573.7% | – | – | – | -1,711.9% | 459.6% | |
| – | – | – | -726.3% | -1,607.6% | -2,006.0% | – | – | – | -5,405.8% | -252.4% |
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.